Literature DB >> 18442131

Red flags for multiple system atrophy.

Martin Köllensperger1, Felix Geser, Klaus Seppi, Michaela Stampfer-Kountchev, Martin Sawires, Christoph Scherfler, Sylvia Boesch, Joerg Mueller, Vasiliki Koukouni, Niall Quinn, Maria Teresa Pellecchia, Paolo Barone, Nicole Schimke, Richard Dodel, Wolfgang Oertel, Erik Dupont, Karen Østergaard, Christine Daniels, Günther Deuschl, Tanya Gurevich, Nir Giladi, Miguel Coelho, Cristina Sampaio, Christer Nilsson, Håkan Widner, Francesca Del Sorbo, Alberto Albanese, Adriana Cardozo, Eduardo Tolosa, Michael Abele, Thomas Klockgether, Christoph Kamm, Thomas Gasser, Ruth Djaldetti, Carlo Colosimo, Giuseppe Meco, Anette Schrag, Werner Poewe, Gregor K Wenning.   

Abstract

The clinical diagnosis of multiple system atrophy (MSA) is fraught with difficulty and there are no pathognomonic features to discriminate the parkinsonian variant (MSA-P) from Parkinson's disease (PD). Besides the poor response to levodopa, and the additional presence of pyramidal or cerebellar signs (ataxia) or autonomic failure as major diagnostic criteria, certain other clinical features known as "red flags" or warning signs may raise the clinical suspicion of MSA. To study the diagnostic role of these features in MSA-P versus PD patients, a standardized red flag check list (RFCL) developed by the European MSA Study Group (EMSA-SG) was administered to 57 patients with probable MSA-P and 116 patients with probable PD diagnosed according to established criteria. Those red flags with a specifity over 95% were selected for further analysis. Factor analysis was applied to reduce the number of red flags. The resulting set was then applied to 17 patients with possible MSA-P who on follow-up fulfilled criteria of probable MSA-P. Red flags were grouped into related categories. With two or more of six red flag categories present specificity was 98.3% and sensitivity was 84.2% in our cohort. When applying these criteria to patients with possible MSA-P, 76.5% of them would have been correctly diagnosed as probable MSA-P 15.9 (+/-7.0) months earlier than with the Consensus criteria alone. We propose a combination of two out of six red flag categories as additional diagnostic criteria for probable MSA-P. (c) 2008 Movement Disorder Society

Entities:  

Mesh:

Year:  2008        PMID: 18442131     DOI: 10.1002/mds.21992

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  58 in total

Review 1.  Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases.

Authors:  Michael G Erkkinen; Mee-Ohk Kim; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

Review 2.  [Diagnostics of clinical and prodromal idiopathic Parkinson's disease : New criteria].

Authors:  H Zach; U Walter; I Liepelt-Scarfone; W Maetzler
Journal:  Nervenarzt       Date:  2017-04       Impact factor: 1.214

Review 3.  Differentiation of atypical Parkinson syndromes.

Authors:  Günter U Höglinger; Jan Kassubek; Ilona Csoti; Reinhard Ehret; Heinz Herbst; Ingmar Wellach; Jürgen Winkler; Wolfgang H Jost
Journal:  J Neural Transm (Vienna)       Date:  2017-02-27       Impact factor: 3.575

Review 4.  Recognizing Atypical Parkinsonisms: "Red Flags" and Therapeutic Approaches.

Authors:  Nikolaus R McFarland; Christopher W Hess
Journal:  Semin Neurol       Date:  2017-05-16       Impact factor: 3.420

5.  Deep brain stimulation response in pathologically confirmed cases of multiple system atrophy.

Authors:  Michael Ullman; Vinata Vedam-Mai; Andrew S Resnick; Anthony T Yachnis; Nikolaus R McFarland; Stacy Merritt; Pamela Zeilman; Kelly D Foote; Michael S Okun
Journal:  Parkinsonism Relat Disord       Date:  2011-10-07       Impact factor: 4.891

Review 6.  Diagnostic Approach to Atypical Parkinsonian Syndromes.

Authors:  Nikolaus R McFarland
Journal:  Continuum (Minneap Minn)       Date:  2016-08

Review 7.  The Differential Diagnosis and Treatment of Atypical Parkinsonism.

Authors:  Johannes Levin; Alexander Kurz; Thomas Arzberger; Armin Giese; Günter U Höglinger
Journal:  Dtsch Arztebl Int       Date:  2016-02-05       Impact factor: 5.594

Review 8.  Treatable inherited rare movement disorders.

Authors:  H A Jinnah; Alberto Albanese; Kailash P Bhatia; Francisco Cardoso; Gustavo Da Prat; Tom J de Koning; Alberto J Espay; Victor Fung; Pedro J Garcia-Ruiz; Oscar Gershanik; Joseph Jankovic; Ryuji Kaji; Katya Kotschet; Connie Marras; Janis M Miyasaki; Francesca Morgante; Alexander Munchau; Pramod Kumar Pal; Maria C Rodriguez Oroz; Mayela Rodríguez-Violante; Ludger Schöls; Maria Stamelou; Marina Tijssen; Claudia Uribe Roca; Andres de la Cerda; Emilia M Gatto
Journal:  Mov Disord       Date:  2017-09-01       Impact factor: 10.338

Review 9.  Diagnosis of multiple system atrophy.

Authors:  Jose-Alberto Palma; Lucy Norcliffe-Kaufmann; Horacio Kaufmann
Journal:  Auton Neurosci       Date:  2017-10-23       Impact factor: 3.145

10.  Sleep dysfunction in multiple system atrophy.

Authors:  Luigi Ferini-Strambi; Sara Marelli
Journal:  Curr Treat Options Neurol       Date:  2012-10       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.